Christophe A, Robberecht E, De Baets F, Franckx H
Department of Nutrition, State University of Gent, Belgium.
Ann Nutr Metab. 1992;36(5-6):304-12. doi: 10.1159/000177734.
We studied the effects of supplementing patients with cystic fibrosis for 1 month with 3 g/day of a dietary supplement, containing 911 mg omega 3 fatty acids, on the fatty acid composition of serum cholesterol esters, free fatty acids, phospholipids and triglycerides. At the end of the supplementation period, the content of total omega 3 fatty acids was increased significantly in all lipid classes. The effect on individual omega 3 fatty acids depended on the fatty acid and lipid class studied, increased with the dose fed and decreased with the weight of the patient. One month after the end of the supplementation period, fatty acid levels had returned to pretreatment values. These results demonstrate that enrichment of serum lipid classes with omega 3 fatty acids is feasible in CF patients by dietary supplementation.
我们研究了给囊性纤维化患者每日补充3克含有911毫克ω-3脂肪酸的膳食补充剂,为期1个月,对血清胆固醇酯、游离脂肪酸、磷脂和甘油三酯的脂肪酸组成的影响。在补充期结束时,所有脂质类别中总ω-3脂肪酸的含量均显著增加。对单个ω-3脂肪酸的影响取决于所研究的脂肪酸和脂质类别,随喂食剂量增加而增加,随患者体重降低而降低。在补充期结束1个月后,脂肪酸水平已恢复到治疗前值。这些结果表明,通过膳食补充使囊性纤维化患者血清脂质类别富含ω-3脂肪酸是可行的。